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pen accessAbstract Background: This study was conducted to investigate the anaesthetic, vasodilator, and
post-operative analgesic sparing effect of bilateral sphenopalatine ganglion block (SPGB) in
patients undergoing endoscopic endo-nasal trans-sphenoidal surgery.
Methods: Thirty adult patients of ASA (I, II), aged 20–60 years, were randomly allocated to either
the block group or the non-block group (n= 15, for each). After establishment of general anesthe-
sia with sevoﬂurane and 100% oxygen, the patients received bilateral SPGB with 1.5 ml of either
0.5% bupivacaine (block group) or 0.9% NaCl (non-block group). Intra-operative mean arterial
pressure (MAP) was maintained at 60–65 mmHg by using nitroglycerine. End-tidal sevoﬂurane
concentration required to maintain bispectral index values (40–50) throughout the operation was
recorded. Nitroglycerine and propranolol consumption, blood loss, recovery proﬁle, perioperative
catecholamines, post-operative pain and meperidine consumption were evaluated.
Results: Block group showed signiﬁcant decrease in sevoﬂurane and nitroglycerine consumption,
blood loss, emergence time and time needed to achieveP9 Aldrete score, P< 0.0001. All patients
in non-blockade group (100%) were supplemented by nitroglycerine to achieve the target MAP ver-
sus 9 patients (60%) in the block group (P< 0.01). Propranolol administration was necessary in 9
patients (60%) in the non-block group versus 3 patients (20%) in the block group, P< 0.05. Atm (A.R. Ali).
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274 A.R. Ali et al.PACU, visual analogue pain score and number of patients received meperidine analgesia were sig-
niﬁcantly less in the block group versus non-block group, P< 0.0001 and P< 0.001, respectively.
Intra- and post-operative plasma epinephrine and nor-epinephrine levels were signiﬁcantly higher in
the non-block group than the block group, P< 0.05.
Conclusion: Bilateral SPGB has anaesthetic, vasodilator and analgesic sparing effect when com-
bined with general anaesthesia during endoscopic endo-nasal trans-sphenoidal resection of pituitary
adenoma.
ª 2010 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Microsurgical trans-sphenoidal approaches have been estab-
lished as the standard surgical treatment for pituitary adeno-
mas [1]. Improved endoscopes and the tendency of surgeons
to advance surgical techniques have led to development of
endoscopic trans-nasal applications in many pituitary surgical
centres [2–5].
Although the endoscopic trans-nasal approach is minimally
invasive and less traumatic procedure, it is associated with in-
tense painful stimulation during the nasal, sphenoidal and sel-
lar phases of the operation [6]. The magnitude of painful
stimulation can ﬂuctuate widely during the procedure leading
to sudden increases in arterial pressure [7]. So control of in-
tra-operative blood pressure is necessary to reduce bleeding
and improve the quality of surgical ﬁeld.
Many approaches have been used to attenuate the hyper-
tensive response to such stimuli, including increase the depth
of anaesthesia, infusion of vasodilators and inﬁltration of
higher concentration of lidocaine in adrenaline solution [6–8].
It is assumed that the use of regional block, as an adju-
vant to general anaesthesia, is effective during endo-nasal
trans-sphenoidal surgery. Many regional techniques have
been used during resection of pituitary adenoma including
inﬁltration of local anaesthetics [7], bilateral maxillary nerve
block [9] and bilateral infraorbital nerve block [10].
The sphenopalatine ganglion (SPG) is one of parasympa-
thetic ganglia in the head. It is located in the pterygopalatine
fossa, posterior to the middle nasal turbinate under a 1–5 mm
layer of connective tissue and mucous membrane, anterior to
the pterygoid canal and lateral to sphenopalatine foramen
[11,12]. It has sensory effects through trigeminal and facial
nerves, visceral motor function through parasympathetic
activity of superﬁcial petrosal nerve and sympathetic function
through its connection to the cervical sympathetic chain via
the great deep petrosal nerve [13]. The sensory ﬁbers connect
the maxillary nerve to the SPG by ﬁve branches that extend
from the nasopharynx, nasal cavity, nasal sinuses, palate, and
orbit [11]. Blocking the SPG relies on block of these branches
of maxillary nerve [11].
There are many approaches to block this ganglion [11].
Trans-nasal endoscopic injection approach is the most recent
one [14–17]. The blockade of this ganglion has been used to
treat headache and facial pain [15]. However, there are limited
clinical studies investigating its efﬁcacy during and after
surgery [18,19]. In the literature search, there was no data
concerning its usage during endoscopic endo-nasal trans-sphe-
noidal resection of pituitary adenoma.
The present prospective randomized double blinded con-
trolled study was designed to evaluate the anaesthetic, vasodi-
lator, and post-operative analgesic sparing effect of bilateraltrans-nasal sphenopalatine ganglion block (SPGB) combined
with general anaesthesia during endoscopic trans-nasal resec-
tion of pituitary adenoma.
2. Methods
This study was conducted at Kasr El-Aini hospital, Cairo Uni-
versity, from February 2007 to September 2008. After ap-
proval of Local Ethical Committee, informed consents were
obtained from all patients. Thirty adult patients of ASA phys-
ical status I and II, aged 20–60 years, who were scheduled for
elective endoscopic trans-nasal excision of pituitary adenoma,
were enrolled in this prospective, randomized, double-blinded,
controlled study. Detailed endocrinal functions were evaluated
preoperatively and all patients received the appropriate
pre-operative therapy. Pre-operative assessment included
complete blood picture, serum electrolytes, liver function tests,
serum creatinine, blood glucose level, coagulation proﬁle and a
12-lead ECG. Exclusion criteria included disturbed level of
consciousness, bleeding disorder, elevated intracranial pres-
sure, or history of hepatic, renal or cardio-pulmonary dysfunc-
tion. Patients receiving cardiovascular active medications or
drugs inﬂuencing blood coagulation were also excluded.
The night before surgery, all patients were taught how to
assess their pain using a 10-cm visual analogue score (VAS),
with 0 representing no pain at all and 10 representing the worst
imaginable pain.
In the holding area, a 20G radial artery Teﬂon cannula
was inserted under local anaesthesia after Allen’s test for direct
arterial blood pressure measurement and blood sampling. One
20G intravenous line was secured for administration of anaes-
thetic drugs and ﬂuids. All patients were premedicated with i.v.
0.02 mg/kg midazolam.
On arrival to the operating room, routine monitors includ-
ing pulse oximeter, ﬁve-lead ECG and invasive arterial blood
pressure were instituted. (Inﬁnity SC 8000, Dra¨ger medical sys-
tem, Avenue, Danvers, MA, USA). Standard BIS monitor
strip (BISX, Aspect medical Systems, Norwood, MA,
USA) was placed on the patients forehead of the dominant
hemisphere according to the guidelines of the manufacture.
General anaesthesia was induced with intravenous fentanyl
2 lg/kg, propofol 2–3 mg/kg and lidocaine 0.5 mg/kg to reduce
pain on injection. Endotracheal intubation was facilitated with
i.v. vecuronium 0.08 mg/kg and oropharyngeal pack was ap-
plied. General anaesthesia was maintained using sevoﬂurane
in 100% oxygen, and vecuronium. All patients were mechani-
cally ventilated to maintain end-tidal carbon dioxide between
35 and 40 mmHg. Depth of anaesthesia was controlled by
Bispectral Index and sevoﬂurane concentration was titrated
to achieve a BIS value between 40 and 50 throughout the in-
tra-operative period.
Figure 1 The endoscopic view showing the nasal cavity before
needle insertion. M.T., middle turbinate; I.T., inferior turbinate;
N.Ph, nasopharynx; Sph. P.F., assumed place of sphenopalatine
foramen.
Figure 2 Under endoscopic control (4 mm, 0), long, 20-gauge
needle is passed between middle and inferior turbinate and
inserted in mucosa just behind and over middle turbinate tail,
seeking sphenopalatine foramen. M.T., middle turbinate; I.T.,
inferior turbinate; N.Ph, nasopharynx.
Table 1 Average category scale [20].
0 No bleeding
1 Slight bleeding – no suctioning of blood required
2 Slight bleeding – occasional suctioning required. Surgical
ﬁeld not threatened
3 Slight bleeding – frequent suctioning required. Bleeding
threatens surgical ﬁeld a few seconds after suction is
removed
4 Moderate bleeding – frequent suctioning required.
Bleeding threatens surgical ﬁeld directly after suction is
removed
5 Severe bleeding – constant suctioning required. Bleeding
appears faster than can be removed by suction. Surgical
ﬁeld severely threatened and surgery not possible
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sion line) was secured.
After achieving satisfactory level of anaesthesia (BIS value
between 40 and 50), patients were randomly allocated accord-
ing to sealed envelope method to one of two groups, block
group and non-block group (n= 15, for each). Both groups
assigned to receive bilateral sphenopalatine ganglion block
(SPGB) using 1.5 ml of either 0.5% bupivacaine in block
group or normal saline (placebo) in non-block group. Both
bupivacaine and placebo solution were prepared by anaesthe-
siology resident, who was blinded to the recorded data. The
surgical team and the anaesthetist managing the patients intra-
operatively, were blinded to the drug being administered.
2.1. Technique of SPGB
Patients were placed in 15 degree reverse Trendlenburg posi-
tion and the nasal cavity, between the middle and inferior tur-
binates, from nares to posterolateral wall of the nasopharynx
was anesthetized topically with 1.5% lidocaine + 1:200,000
epinephrine using cotton-tipped applicators. This passage
was sterilized by an additional cotton-tipped applicator soaked
with iodine solution. A 20-gauge/5-in. spinal needle was used
after bending 2–3 mm of its tip along the port side with a ster-
ile needle holder to form a 45 angle. The needle was lubricated
with 5% lidocaine jelly, inserted into the nasal meatus and
advanced with the bevel pointer facing laterally. Under endo-
scopic control (0 optics, 4 mm diameter), the needle was in-
serted between middle and inferior turbinate. About 1.5 mL
of either 0.5% bupivacaine or 0.9% NaCl, according to group
assignment, was injected after negative aspiration into the
nasal mucosa just behind and over middle turbinate tail, where
the pterygopalatine fossa is deeply located, (Figs. 1 and 2). The
needle was ﬂushed and removed. Dry cotton-tipped applicator
was inserted down to assure no bleeding after needle removal
[16].
Target intra-operative MAP of 60–65 mmHg, was achieved
by adjustment of nitroglycerine infusion from 0.5 to 10 lg/kg/
min according to patient response.
In case of reﬂex persistent increase in HR> 100 beats/min,
i.v. 0.2 mg increments of propranolol was given to maintain
HR< 100 beats/min. Bradycadia (HR< 45 beats/min) was
treated by i.v. 300 lg increments of atropine.
When MAP reached the required level (60–65 mmHg), and
maintained for 15 min, the surgeon, blinded to group assign-
ment and haemodynamic parameters, was asked to evaluate
the quality of the operative ﬁeld every 30 min intraoperatively
using a pre-deﬁned average category scale (ACS) (from 0 to 5)
adapted from Fromme et al. [20] (Table 1). The ideal category
scale values for surgical conditions were pre-determined to be 2
and 3. The same surgical team performed all operations to en-
sure consistency in evaluation of the operative ﬁeld.
2.2. Surgical technique
Depending on the pre-operative assessment of the patients’ na-
sal passageway either a 4 mm or 2.7 mm (StortzR, Culver City,
CA) endoscope was used. The middle turbinate was resected
using a 0 rigid endoscope. Under direct visualization, sphe-
noidal ostium was identiﬁed and enlarged with Kerrison rong-
eurs. The sphenoidal rostrum and posterior vomer were
removed to open the whole anterior wall of the sphenoid sinus.
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and initial tumour resection. Once tumor resection was com-
pleted or residual tumor was outside the ﬁeld of view, the 0
endoscope was withdrawn and a 30 endoscope was inserted.
Rotating the 30 endoscope clockwise and counter-clockwise
provides visualization of suprasellar and parasellar tumor
extension, including invasion into the cavernous sinus if pres-
ent. The area was irrigated and haemostasis was obtained. An
abdominal fat graft was harvested and used to reconstruct the
sellar defect, which was then sealed using ﬁbrin glue, fat, and
fascia lata packing. No nasal packing was required, and only
a small gauze dressing was placed below the nares to collect
any residual blood or debris.
BIS value and end-tidal sevoﬂurane concentration were
recorded intraoperatively every 5 min. At the conclusion of
surgery, sevoﬂurane together with all infusions, were discon-
tinued. The total amount of nitroglycerine administered to
achieve the target MAP and frequency of propranolol usage
were recorded. All patients received i.v. 15 mg/kg paracetamol
(perfalgan 1 g) at the end of the surgery before extubation.
Ondansetron (4 mg i.v.) as antiemetic agent was propholacti-
cally administered at the end of the surgery to all patients.
Residual neuromuscular block was antagonized with neo-
stigmine (0.05 mg/kg) and atropine (0.01 mg/kg) and trachea
was extubated. Emergence time, deﬁned as the interval be-
tween the discontinuation of anaesthetics to response of eye
opening to verbal command [21], was recorded for all patients.
Intra-operative blood loss (estimated by measuring the vol-
ume of the blood in the suction canister minus the normal sal-
ine used to wash the surgical cavity) was recorded.
After tracheal extubation, all patients transferred to the
post-anaesthesia care unit (PACU) where they were closely
monitored by research assistant, who was blinded to group
allocation, for 3 h.Table 2 Postoperative modiﬁed Alderet recovery score [22].
Description Score
Consciousness
Fully awake and oriented (name, place, date) 2
Arousable on calling 1
Not responding 0
Activity
Moves all four extremities voluntary or on command 2
Moves two extremities 1
Unable to move extremities 0
Respiration
Breathes deeply and coughs freely 2
Dyspnea, limited breathing or tachypnea 1
Apnea or on mechanical ventilation 0
Circulation
Blood pressure ± 20% pre-anesthetic level 2
Blood pressure ± 20–49% pre-anesthetic level 1
Blood pressure ± 50% pre-anesthetic level 0
Oxygen saturation
SpO2 >92% on room air 2
Supplemental O2 is required to keep saturation >90% 1
SpO2 <92% with O2 supplementation 0
Maximum score 10Post-operative recovery was evaluated using a modiﬁed
Alderet score (0–10) [22] (Table 2) and time needed to
achieveP9 was recorded. Post-operative pain was assessed
by VAS (0–10) at PACU admission when the patient was able
to communicate (T0), every 30 min for 3 h (T1–T6). VAS
greater than 3 was managed with incremental i.v. doses of
meperidine 10 mg. Number of meperidine doses in PACU
was calculated. Number of patients who received meperidine
in the PACU was also recorded. The incidence of post-opera-
tive side effects such as post-operative nausea and vomiting
(PONV), headache, visual disturbances, agitation or somno-
lence were recorded.
Arterial blood samples were taken immediately pre-induc-
tion (T0), 1 h after start of surgery (T1), 2 h postoperatively
(T2) for measurements of epinephrine and nor-epinephrine.
The samples were collected into prechilled tubes containing
EDTA–Na and immediately centrifuged at 3000 rpm for
15 min at 4 C. The plasma was stored at 70 C until assayed
for catecholamine concentrations. Plasma epinephrine and
norepinephrine were separated using a Bio Rad column chro-
matography (150 · 4 mm, Part No. GSOD40512S2504) by iso-
cratic elution with a mixture of 6.9 g sodium phosphate, 37 mg
EDTA, 150 mg sodium octane sulfonate, 60 mL acetonitrile,
5 mL of THF and the rest made up to 1000 mL with water
in around 20 min and detected by electrochemical detection.
The results of epinephrine and nor epinephrine were analysed
and the assay sensitivity was 10.0 pg/ml and within non-preci-
sion coefﬁcient of variation were 13.5% and 14.2% for nor epi-
nephrine and epinephrine, respectively.
The primary outcome of the present study was assessing the
effect of SPGB combined with general anaesthesia in sevoﬂu-
rane and nitroglycerine consumption to control the intra-oper-
ative ﬂuctuation of haemodynamics and to achieve intra-
operative MAP between 60 and 65 mmHg during trans-nasal
trans-sphenoidal resection of pituitary adenoma.
Initial sample size estimation showed that approximately 12
patients should be included in each group to ensure a power of
0.80 for detecting a 25% or more decrease in end-tidal sevoﬂu-
rane consumption between the two groups. The standard devi-
ation of end-tidal sevoﬂurane, estimated from initial pilot
observation was approximately 0.38%. The a error assumed
to be 0.05. We made a priori decision to evaluate 15 patients
in each group.
2.3. Statistical analysis
Data were presented as mean (SD) median (25–75th percen-
tiles) or number (%) as appropriate. Comparison between
the two groups was performed using unpaired student’s t test.
Intra-group comparisons of stress hormone relative to baseline
were performed using repeated measure analysis of variance
(ANOVA) with post hoc Dunnet’s test if ANOVA results were
signiﬁcant. Ordinal data were compared using Mann–Whitney
U test. Categorical variable were compared using Chi-squared
or Fisher’s exact tests as appropriate. A P value less than 0.05
was considered statistically signiﬁcant.3. Results
Forty two patients were assessed for study eligibility (8 pa-
tients failed to meet the inclusion criteria and 4 patients refused
Table 3 Demographic and operative data. [mean (SD), ratio
or number].
Non-block group
(n= 15)
Block group
(n= 15)
Age (years) 48 (7) 44 (4)
Sex (M/F) 10/5 9/6
ASA status (I/II) 6/9 7/8
Weight (kg) 79 (6) 82 (7)
Types of pituitary adenoma (n)
Non-functioning adenoma 7 9
Functioning adenoma 8 6
Duration of surgery (min) 151 (18.4) 149 (19.1)
ASA, American society of anaesthesiologists.
Table 4 Postoperative analgesic requirements at PACU
[mean (SD), or number (%)].
Non-block
group (n= 15)
Block group
(n= 15)
No. of patients received meperidine
(percentage)
12 (80%) 2 (13.2%)
No. of patients required diﬀerent meperidine doses at PACU
(percentage)
1 dose 0 (0%) 0 (0%)
2 doses 0 (0%) 0 (0%)
3 doses 0 (0%) 1 (6.6%)
4 doses 1 (6.6%) 1 (6.6%)
5 doses 6 (40%)* 0 (0%)
6 doses 5 (33%)** 0 (0%)
 P< 0.001.
* P< 0.01.
** P< 0.05 compared to the block group.
Sphenopalatine ganglion block and pituitary adenoma 277to sign the consent form). The remaining 30 consenting pa-
tients who fulﬁlled the entry criteria were enrolled in this study.
All patients were able to complete the entire study and their
data were included in ﬁnal analysis. Patients in the two groups
of the study were comparable with respect to demographic
data and duration of surgery (Table 3).
Mean end-tidal sevoﬂurane concentration required to
maintain BIS value between 40 and 50 was signiﬁcantly higher
in non-block than block group [1.8 (0.32)% versus 1.3 (0.27)%
in respectively, P< 0.0001]. All patients in non-block group
(100%) were supplemented by nitroglycerine to achieve the
target MAP versus 9 patients (60%) in the block group, P
< 0.01. The mean nitroglycerine dose required for patients
who needed supplementation in the block group was signiﬁ-
cantly lower than that required in non-block group [1.02
(0.22) lg/kg/min versus 3.1 (0.82) lg/kg/min, respectively,
P< 0.0001]. Propranolol administration was necessary for 9
patients (60%) in the non-block group versus 3 patient
(20%) in the block group, P< 0.05.
The average category scale (ACS) for quality of surgical
ﬁeld was comparable in both groups in the range of MAP
60–65 mmHg at all studied time interval [2 (2–3) in block
group versus 3 (2–3) in non-block group, P= 0.105].
Intra-operative blood loss was signiﬁcantly less in the block
group [215.9 (28.7) ml] when compared to non-block groupFigure 3 Postoperative visual analogue pain score in both groups.
T0 = PACU admission when the patient was able to communicate,
group.[352.6 (32.4) ml], P< 0.0001. No patients required blood
transfusion or presented with excessive blood loss.
Emergence time and time needed to achieveP9 of modiﬁed
Aldrete score were signiﬁcantly shorter in block group than
non-block group [5.4 (1.21) min and 7.2 (1.4) min versus 7.92
(1.88) min and 10.9 (2.9) min, respectively], P< 0.0001.
Visual analogue pain scale was signiﬁcantly lower in block
group than non-block group till the 2nd post-operative hour,
P< 0.0001 (Fig. 3). Twelve patients (80%) in non-block group
compared to only two patients (13.2%) in the block group re-
ceived supplementary meperidine analgesia at the PACU,
P< 0.001. The number of meperidine doses was signiﬁcantly
less in the block group versus non-block group, P< 0.01
(Table 4).
Concerning the plasma epinephrine and nor-epinephrine
levels, the non-block group showed statistically signiﬁcant in-
crease in the intra and post-operative measurements compared
to their baseline values (P< 0.01) and to the corresponding
measurements in the block group, (P< 0.05). However in
the block group, there was not any signiﬁcant difference in
the intra or post-operative measurements comparing to their
baseline values (Figs. 4 and 5).Values are means and error bars represent standard deviation.
T1–T6 = every 30 min at PACU. *P< 0.0001 versus non-block
Figure 4 Perioerative plasma epinephrine concentrations in both
groups. Values are means and error bars represent standard
deviation. T0 = baseline (immediately before induction),
T1 = 1 h intraoperatively, T2 = 2 h postoperatively. *P< 0.05
versus baseline. P< 0.05 versus the block group.
Figure 5 Perioerative plasma nor-epinephrine concentrations in
both groups. Values are means and error bars represent standard
deviation. T0 = baseline (immediately before induction),
T1 = 1 h intraoperatively, T2 = 2 h postoperatively. *P< 0.05
versus baseline. P< 0.05 versus the block group.
Table 5 Incidence of post-operative side effects in both
groups at PACU. [number (%)].
Non-block
group
(n= 20)
Block
group
(n= 20)
Incidence of post-operative side eﬀects [n (%)]
Nausea & vomiting 3 (20%) 2 (13.2%)
Agitation 2 (13.2%) 1 (6.1%)
Headache 1 (6.1%) 0 (0%)
Somelance 2 (13.2%) 1 (6.1%)
Visual disturbances 0 (0%) 0 (0%)
Nasal bleeding 0 (0%) 0 (0%)
Patients received supplemental antiemetic
[n (%)]
2 (13.2%) 2 (13.2%)
278 A.R. Ali et al.The incidence of post-operative complications and number
of patients received supplemental antiemetic were comparable
in both groups (Table 5).4. Discussion
In the endoscopic endo-nasal trans-sphenoidal surgical ap-
proach, the general aims of anaesthesia include optimizing
the intra-operative surgical condition, preventing intra-opera-
tive complications and providing rapid emergence to facilitate
neurological assessment. The present study shows that bilateral
sphenopalatine ganglion block (SPGB) is an effective and safe
technique when combined with general anaesthesia during
endoscopic endo-nasal trans-sphenoidal resection of pituitary
adenoma. Blocking the SPG provided reduction of sevoﬂurane
and nitroglycerine consumption, suppression of haemody-
namic ﬂuctuation during surgical stimulation, less intra-opera-
tive blood loss, faster recovery and suppressed catecholamine
(epinephrine and norepinephrine) response as well as reduction
of post-operative pain and analgesic requirements.
There are three approaches to establish the blockade of
SPG, trans-nasal, transoral and lateral approaches [11]. The
trans-nasal injection technique either blindly or with assistance
of nasal speculum carries the risk of nasal mucosa sloughing
during injection [11,23]. This led to the development of the
trans-nasal endoscopic technique in which the needle inﬁltra-
tion was performed under direct vision using rigid sinuscope
[24]. In the present study the endoscopic guided trans-nasal
injection technique was chosen to block the SPG to ensure
the safety and accuracy of the block.
The bispecteral index (BIS) monitor is a valuable objective
tool to measure anaesthetic depth [25]. It is used to guide
administration of anaesthetics to reduce the risk of intra-oper-
ative awareness, faster the emergence and improve the recov-
ery [26,27]. In the present study the sevoﬂurane was titrated
guided by BIS monitor to achieve an adequate level of hypno-
sis (BIS between 40 and 50) in both groups.
The mean end-tidal sevoﬂurane consumption in the current
study was signiﬁcantly lower in block group compared to non-
block groups. This ﬁnding coincides with the results of previ-
ous studies in which the combination of regional blockade with
general anaesthesia was proved to decrease the anaesthetic
requirements [19,28,29]. Guignard et al. [30] and Ropke et
al. [31] have reported that BIS value increases in response to
nociceptive stimulation during anaesthesia. Another study
done by Hodgson and Liu [32], demonstrated that the deaffer-
entation induced by regional anaesthesia results in supraspinal
effects that change hypnotic anaesthetic requirement [32]. This
may explain the signiﬁcant difference in end-tidal sevoﬂurane
requirement between the two groups in the current study.
The use of SPGB in combination with general anaesthesia
in the present study successfully blocked the intense ﬂuctuating
painful stimulation occurring during different phases of sur-
gery and controlled the intra-operative hemodynamics. This
effect was evident as, the target MAP was achieved with signif-
icantly less sevoﬂurane, nitroglycerine and propranolol con-
sumption in the block group than non-block group.
The effect of SPGB regarding haemodynamic in the present
study could be attributed to the adequate and extensive anaes-
thesia achieved to the nasal cavity and paranasal sinuses. This
ﬁnding coincides with the results of previous two studies which
evaluated the efﬁcacy of bilateral maxillary nerve block during
trans-sphenoidal surgery [9] and endoscopic endo-nasal SPGB
during sinonasal surgery [19]. Another study evaluating the
effect of regional nerve block combined with general
anaesthesia during oral surgery, reported that the dose of
Sphenopalatine ganglion block and pituitary adenoma 279adenosine required for inducing and maintaining hypotension
was reduced under stabilized hemodynamics achieved by nerve
blocks [33].
The main purpose of blood pressure control during endo-
scopic trans-sphenoidal surgery is to provide a dry ﬁeld for
the surgeon to improve visibility and facilitate the surgical ap-
proach. To achieve these goals attention to surgical ﬁeld might
be a better monitor than absolute MAP [8].
In the current study, with the same level of MAP (60–
65 mmHg); the surgical ﬁeld was comparable in both groups.
However the ACS in block group reached ideal levels (2–3)
with no or minimal consumption of hypotensive agents com-
pared to non-block group.
The blood loss was signiﬁcantly less in blockade group com-
pared to non-blockade group. These ﬁndings are in line with re-
sults of previous study evaluating bilateral SPGBcombinedwith
general anaesthesia during endoscopic sinus surgery [19]. Para-
sympathetic block allowing unopposed sympathetic activity
may be themechanism of haemostasis obtained with SPGB [23].
Although the organic nitrate vasodilators inhibit platelets
via production of nitric oxide [34], it is unclear whether this
is the contributing factor in the increased bleeding in the sur-
gical ﬁeld for the non-block group as nitroglycerine consump-
tion was signiﬁcantly higher than in the block group.
Complete awakening and orientation immediately after the
termination of surgery is highly desirable when early neurolog-
ical evaluation is needed [8]. The emergence time (time to re-
spond to verbal command) and time needed to achieve
Aldrete scoreP9 in the current study were signiﬁcantly short-
er in the block group when compared to the non-block group.
This difference could be attributed to the signiﬁcantly less
sevoﬂurane consumption in the block group compared to
non-block group.
In the present study VAS pain score was signiﬁcantly lower
in the block group than the non-block group during the imme-
diate post-operative period. In non-block group paracetamol
alone was insufﬁcient, as 16 patients (80%) had a score of
pain >3 and required meperidine in the ﬁrst 2 h at PACU.
At 150 min, the VAS score between the two groups was com-
parable. However meperidine consumption was signiﬁcantly
higher in the non-block group.
Regional anaesthesia is an appropriate component of mul-
timodal analgesia in this setting. Furthermore, SPG blockade
may also contribute to decreased mechanical hyperalgesia in-
duced by inﬂammation [35,36].
This ﬁnding is in line with previous studies, where post-
operative pain intensity was lower in the block group than in
the non-block group [18,19].
The surgical stress response includes a complex series of
neuro-endocrine response. Stress response hormone levels
can serve as an objective method to assess the analgesic efﬁ-
cacy of various regional techniques [37]. Reduction of the
stress response is highly dependent on the surgical site, and
the analgesic technique [37].
In the current study, the SPGB had suppressed the cate-
cholamine response to surgical stimulus and post-operative
pain in the block group while the non-block group showed sig-
niﬁcant increase in plasma epinephrine and nor-epinephrine
during the intra- and post-operative periods. Similar ﬁndings
were reported in previous clinical studies investigating the ef-
fect of combination of nerve block with general anaesthesia
in oral surgery [29,33]. The suppressed catecholamine responsein the block group is probably related to the blockade of the
afferent nociceptive impulses from the surgical site to the
hypothalamus, which in turn inhibits the pituitary adrenocor-
tical axis stimulation [37].
These ﬁndings coincides with the other ﬁndings of the pres-
ent study regarding, the intra-operative haemodynamic stabil-
ity and less post-operative pain scores in the block group.
Moreover it reﬂects the intra- and post-operative analgesic ef-
fect of SPGB during trans-sphenoidal surgery.
Further studies are required to evaluate the opioid-sparing
effects of this block in the intra-operative period.
In conclusion, concomitant use of bilateral SPGB with gen-
eral anaesthesia is effective and safe technique during endo-
scopic endo-nasal trans-sphenoidal resection of pituitary
adenoma. It provides adequate intra- and post-operative anal-
gesia which led to stable hemodynamics during surgery with
less sevoﬂurane and nitroglycerine consumption, less intra-
operative blood loss, faster recovery and suppressed catechol-
amine response in addition to decrease in post-operative pain
and analgesic requirements.References
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